BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 26485238)

  • 1. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
    Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
    Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
    Mittal R; Araujo I; Czanner G; Coupland SE
    Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor).
    Mulay K; White VA; Shah SJ; Honavar SG
    Can J Ophthalmol; 2014 Aug; 49(4):326-32. PubMed ID: 25103648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sebaceous carcinoma: an immunohistochemical reappraisal.
    Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
    Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.
    Chen WS; Chen PL; Li J; Lind AC; Lu D
    J Cutan Pathol; 2013 Jul; 40(7):631-8. PubMed ID: 23557589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
    Jakobiec FA; Werdich X
    Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of adipophilin immunostain in periocular carcinomas.
    Milman T; Schear MJ; Eagle RC
    Ophthalmology; 2014 Apr; 121(4):964-71. PubMed ID: 24290802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining for adipophilin, perilipin and TIP47.
    Muthusamy K; Halbert G; Roberts F
    J Clin Pathol; 2006 Nov; 59(11):1166-70. PubMed ID: 16556662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry in ocular carcinomas.
    Sramek B; Lisle A; Loy T
    J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perilipin and adipophilin expression in sebaceous carcinoma and mimics.
    Boussahmain C; Mochel MC; Hoang MP
    Hum Pathol; 2013 Sep; 44(9):1811-6. PubMed ID: 23642680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
    Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
    Jakobiec FA; Mendoza PR
    Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sebaceous Carcinoma of the Eyelid.
    Prieto-Granada C; Rodriguez-Waitkus P
    Cancer Control; 2016 Apr; 23(2):126-32. PubMed ID: 27218789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
    Ansai S; Arase S; Kawana S; Kimura T
    J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and comparison of staining patterns of factor XIIIa (AC-1A1), adipophilin and GATA3 in sebaceous neoplasia.
    Tjarks BJ; Pownell BR; Evans C; Thompson PA; Kerkvliet AM; Koch MRD; Jassim AD
    J Cutan Pathol; 2018 Jan; 45(1):1-7. PubMed ID: 28873247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
    Asadi-Amoli F; Khoshnevis F; Haeri H; Jahanzad I; Pazira R; Shahsiah R
    Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic use of low molecular weight keratin expression in sebaceous carcinoma.
    Murata T; Nakashima Y; Takeuchi M; Sueishi K; Inomata H
    Pathol Res Pract; 1993 Sep; 189(8):888-93. PubMed ID: 7508102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear cell neoplasms.
    Uhlenhake EE; Clark LN; Smoller BR; Shalin SC; Gardner JM
    J Cutan Pathol; 2016 Aug; 43(8):649-56. PubMed ID: 27153339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.